Abiopharma

🔍 Campe Heather (Executive)

Company: FULLER H B CO (FUL)

Report Date: 2026-06-22

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-22 | Code: H | shares_owned_after: 24,653.08 | Footnotes: F1
• Acquired 35 shares of Phantom Units (Derivative)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,738.39 | transaction_form_type: 4 | Footnotes: F2, F3, F3, F4
• Holds 19,520 shares of Employee Stock Option (Right-to-Buy) at $51.89 per share (Derivative)
  Date: 2026-06-22 | Code: H | Expires: 2031-01-27 | Exercise: 2022-01-27 | shares_owned_after: 19,520.00 | Footnotes: F5
• Holds 21,834 shares of Employee Stock Option (Right-to-Buy) at $53.57 per share (Derivative)
  Date: 2026-06-22 | Code: H | Expires: 2028-01-25 | Exercise: 2019-01-25 | shares_owned_after: 21,834.00 | Footnotes: F5
• Holds 15,177 shares of Employee Stock Option (Right-to-Buy) at $59.81 per share (Derivative)
  Date: 2026-06-22 | Code: H | Expires: 2036-01-26 | Exercise: 2027-01-26 | shares_owned_after: 15,177.00 | Footnotes: F6
• Holds 10,831 shares of Employee Stock Option (Right-to-Buy) at $64.28 per share (Derivative)
  Date: 2026-06-22 | Code: H | Expires: 2035-01-27 | Exercise: 2026-01-27 | shares_owned_after: 10,831.00 | Footnotes: F6
• Holds 10,730 shares of Employee Stock Option (Right-to-Buy) at $68.17 per share (Derivative)
  Date: 2026-06-22 | Code: H | Expires: 2033-01-24 | Exercise: 2024-01-24 | shares_owned_after: 10,730.00 | Footnotes: F5
• Holds 11,636 shares of Employee Stock Option (Right-to-Buy) at $72.94 per share (Derivative)
  Date: 2026-06-22 | Code: H | Expires: 2032-01-24 | Exercise: 2023-01-24 | shares_owned_after: 11,636.00 | Footnotes: F5
• Holds 9,928 shares of Employee Stock Option (Right-to-Buy) at $77.72 per share (Derivative)
  Date: 2026-06-22 | Code: H | Expires: 2034-01-26 | Exercise: 2025-01-26 | shares_owned_after: 9,928.00 | Footnotes: F6
• Holds 585 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-22 | Code: H | Expires: 2027-01-26 | Exercise: 2025-01-26 | shares_owned_after: 585.21 | Footnotes: F7, F8, F9
• Holds 2,255 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-22 | Code: H | Expires: 2029-01-26 | Exercise: 2027-01-26 | shares_owned_after: 2,255.28 | Footnotes: F7, F8, F9
• Holds 1,302 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-22 | Code: H | Expires: 2028-01-27 | Exercise: 2026-01-27 | shares_owned_after: 1,302.18 | Footnotes: F7, F8, F9

Footnotes:

• F1: Amount includes shares acquired pursuant to a dividend reinvestment plan.
• F2: These units (acquired after 12-31-04) convert into shares of common stock on a 1-for-1 basis.
• F3: These units (acquired after 12-31-04) convert into shares of common stock upon the earlier of certain termination events as specified in the Key Employee Deferred Compensation Plan or such earlier date as selected by the participant, subject to holding periods required by law.
• F4: Amount includes stock units acquired pursuant to a dividend equivalent feature.
• F5: This option is 100% vested.
• F6: This option vests in three annual installments (33%, 33%, and 34%) beginning on the date shown.
• F7: These restricted stock units convert into shares of common stock on a 1-for-1 basis.
• F8: These restricted stock units vest in three annual installments (33%, 33%, and 34%) beginning on the date shown.
• F9: Amount includes restricted stock units acquired pursuant to a dividend equivalent reinvestment feature.